Navigation Links
Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks
Date:3/28/2008

Single-Dose, Volunteer fMRI Study Completed and Reported Today

Dosing in Four Week Higher Repeat Dose Study Completed

HAMBURG, Germany and OXFORD, England, March 28 /PRNewswire-FirstCall/ -- Evotec (Frankfurt Stock Exchange: EVT) is pleased to announce the preliminary findings of a double-blind, single-dose, 3-way cross-over study with its orally active NR2B subtype selective NMDA receptor antagonist, EVT 101. The study was performed in 19 healthy young subjects and was conducted at the Centre for Neuroimaging Sciences of the Institute of Psychiatry at King's College London using functional magnetic resonance imaging techniques (fMRI) to investigate short-term effects of two doses of EVT 101 and placebo. The effects of the compound on cognitive endpoints, changes in local cerebral blood flow, reflecting neuronal activation or deactivation during the performance of cognitive tasks, as well as base-line regional cerebral blood flow, were explored.

All treatments were well tolerated confirming previous observations in healthy subjects.

While there was no evidence of acute improvement in cognitive function, an observation not unexpected in healthy young subjects who frequently perform at an optimum level, the activity of a number of brain regions, known for their role as a memory retrieval network, were selectively modified during the performance of certain tasks, as assessed by analysis of the changes in local cerebral blood flow.

Analysis of the changes in basal regional cerebral blood flow indicated a selective increase in blood flow in one specific region of the cortex, an area rich in NMDA receptors which is considered to be significant for indications such as pain and depression. Basal blood flow in other brain areas was unaffected.

These findings represent the first demonstration of effects of EVT 101 on human brain function at doses that are well tolerated and predicted to be clinically relevant.

I
'/>"/>

SOURCE Evotec AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. RediClinic Offers Affordable New Plan Clinically Shown to Double a Persons Chance to Stop Smoking
2. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
3. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
4. Video: New Research Discovers Independent Brain Networks Control Human Walking
5. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
6. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
7. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
8. Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. One Shot of Gene Therapy Spreads Through Brain in Animal Study
11. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 30, 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... the quarter ended March 31, 2015 on Thursday, May ... Regulus will host a conference call and ... Eastern Daylight Time to discuss its first quarter 2015 ...
(Date:4/30/2015)... CUPERTINO, Calif., April 30, 2015  DURECT Corporation (Nasdaq: ... first quarter of 2015.  Total revenues were $4.8 million ... months ended March 31, 2015 as compared to total ... million for the three months ended March 31, 2014.At ... $29.8 million, compared to cash and investments of $34.9 ...
(Date:4/30/2015)... 2015 Pharmacists at Osco Drug have voted to ... Portland, Maine . The newly organized group consists of ... Shaw,s supermarkets throughout Maine . ... in securing them the powerful representation that Teamsters Local 340 ... President of Local 340. "We will work tirelessly, providing them ...
Breaking Medicine Technology:Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces First Quarter 2015 Financial Results and Update of Programs 9
... 02, 2007 /PRNewswire-FirstCall/ - YM,BioSciences Inc. ... develops,and commercializes differentiated products for patients ... randomized,placebo-controlled Phase IIb trial of AeroLEF(TM) ... following orthopedic surgery.,AeroLEF(TM) met the primary ...
... 2, 2007 - Acorda Therapeutics, Inc.(R),(Nasdaq: ACOR) ... clinical trial,of Fampridine-SR in people with multiple ... meeting. Andrew Goodman, M.D.,Director of the Multiple ... top-line results on walking ability, leg,strength, spasticity ...
Cached Medicine Technology:YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 2YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets,Primary Endpoint in Patients with Post-Surgical Pain 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7
(Date:5/1/2015)... The Workgroup for Electronic Data Interchange ... use of health IT to create efficiencies in healthcare ... the United States Government Accountability Office (GAO) for a ... Medicare. The report, “ Potential Uses of Electronically Readable ... the public on Apr. 24, 2015 and examines the ...
(Date:5/1/2015)... Hope For The Warriors® thanks All ... The Warriors® and military families. All American Ford presented ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... collected and matched small autograph fee from fans and ...
(Date:5/1/2015)... 2015 The Quail Creek Relay for Life ... Since 2001, the Quail Creek Relay team has raised almost ... throughout the year, including their biggest event, January’s Dinner and ... , Quail Creek Relay for Life team was established ... Kerwin, fitness director, states, “I was hooked when I learned ...
(Date:5/1/2015)... May 01, 2015 Digital technology and ... pregnant women between prenatal appointments, a preliminary study ... a small sample of low-risk pregnant women, will be ... Washington University Medical Faculty Associates at the 2015 American ... Scientific Meeting, May 2-6. The digital technology used was ...
(Date:5/1/2015)... Veteran Outreach Pittsburgh - Events , The ... VA Vet Centers on May 6, starting at 5 p.m., ... in front of the SouthSide Works Theater, 425 Cinema Drive, ... the documentary, “That Which I Love Destroys Me,” and a ... Please contact Robert Novotney for more information on the VA ...
Breaking Medicine News(10 mins):Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... Innovations, (Pink Sheets: SCLL) ACTIVTox(R) human liver toxicity tests ... standardized human liver cell line to identify potential toxicities ... is available now and can be used to help ... of our ACTIVTox testing system could help prevent recalls ...
... 21 Celator Pharmaceuticals today announced that it ... Inc. (Nasdaq: CEPH ). The ... application of Celator,s proprietary technology to an ongoing ... agreement provides an opportunity to leverage the technology ...
... MDdatacor, Inc ., a leader in health care ... today announced new functionality to support in tracking ... Care Program. The program is a collaboration between Wellmark ... to promote improved quality care and increased efficiency. ...
... Optimize Resources With Imaging, Behavioral and Chronic Management ... is now easier for providers and payors, thanks ... new Milliman Care Guidelines (R) 13th Edition. ... measures within the Care Guidelines, workflow ...
... are out the schoolroom door and off to the ... preventive steps to help protect their hearts.Prevention may be ... exercise, stay away from cigarettes and have check-ups.Be aware ... disorder known as Long QT Syndrome, research shows that ...
... Employer Interest in Their NicheDENVER, May 21 The ... their employees on international business trips to "get proactive" ... the state,s largest travel health provider."We are hearing from ... Reesman, president of Passport Health Colorado. "I think now ...
Cached Medicine News:Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 2Health News:FDA's Hydroxycut Recall Highlights the Need for Stem Cell Innovations' ACTIVTox Human Liver Testing 3Health News:Celator(R) Pharmaceuticals Initiates Research Agreement With Cephalon, Inc. 2Health News:Wellmark Leverages MDdatacor Technology to Streamline Immunization Tracking 2Health News:Wellmark Leverages MDdatacor Technology to Streamline Immunization Tracking 3Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 2Health News:Milliman Care Guidelines(R) Products Drive Efficiency Through Expanded Quality Tools 3Health News:Protect Your Kids' Hearts: Summer Activity Can Trigger Genetic Disorder, Say Results for Life, Sudden Cardiac Arrest Association 2Health News:Protect Your Kids' Hearts: Summer Activity Can Trigger Genetic Disorder, Say Results for Life, Sudden Cardiac Arrest Association 3Health News:H1N1 Scare Causes Businesses to Get Serious About Travel Health 2
... an easy-to-use, automated system that enables you ... for managing hemostatic disordersincluding D-Dimer, Von Willebrand ... reflex and rerun testing for greater efficiency ... our high-quality service to help your lab ...
... RX ACCUNET Embolic Protection System is designed ... filter control when performing carotid stenting interventions. ... based filter system that utilizes rapid exchange ... control the filter during catheter manipulations. It ...
Four disposable disc electrodes are pre-gelled and attached to wires in red, blue, black and green. 4mil carbon film, Ag/AgCl coated. Each package contains 20 individually sealed sets of four leads....
Lancet cut ultra sharp tip for low penetration resistance. Low noise and impedance level giving you a clear and reliable signal. Stainless steel needle, color coded attached lead wires. Needles sold ...
Medicine Products: